
pmid: 27814443
handle: 10147/620920
Tyrosinaemia type 1 (TYR1, OMIM# 276700) is a rare autosomal recessive disease that results from an enzyme defect that leads to a deficiency in fumarylacetoacetase (FAH)1. We present 3 cases of TYR1 in the Irish population over a 9 year period, the only cases known to have been diagnosed in Ireland since 1989. The common presenting symptom was hypoglycaemia and the diagnosis was made by the identification of the pathognomonic biomarker succinylacetone on urine organic acid analysis. We discuss the clinical presentation, biochemical and genetic results including one novel mutation. We also highlight the importance of early initiation of Nitisinone (NTBC), which reduces the complications of TYR1 and the incidence of liver transplantation in this population2.
peer-review
No funding
Leinster
Cyclohexanones, Hydrolases, Tyrosinemias, GENETIC DISORDERS, Hypoglycemia, Heptanoates, Liver Transplantation, Nitrobenzoates, Mutation, Humans, Enzyme Inhibitors, Ireland, Biomarkers
Cyclohexanones, Hydrolases, Tyrosinemias, GENETIC DISORDERS, Hypoglycemia, Heptanoates, Liver Transplantation, Nitrobenzoates, Mutation, Humans, Enzyme Inhibitors, Ireland, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
